Initial module submission marks an important milestone in the pre-market approval process - - Flexible modular submission ...

Bacteria in head and neck tumor stimulate immunotherapy resistance by attracting immune cells and creating a shield.

China NMPA grants breakthrough therapy designation to Kelun-Biotech’s sacituzumab tirumotecan in combo with immunotherapy pembrolizumab for first-line treatment of PD-L1-positive NSCLC ...

Industry star Marisa Abela shared an encouraging health update nearly six years after being diagnosed with thyroid cancer at ...

Science says marry the right person and you’ll be more successful, except for 1 (very personal) catch Archaeologists thought ...

BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ ...

An update from Alpha Tau Medical Ltd ( ($DRTS) ) is now available. On January 5, 2026, Alpha Tau Medical announced it has submitted the first ...

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why ...

Vitamin B3, or niacin, is essential in small amounts for normal body function. The skin, nerves, and digestive system all ...

Summit Therapeutics Inc. (NASDAQ:SMMT) ranks among the best stocks under $25 to buy now. Cantor Fitzgerald reaffirmed its ...